FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

BACKGROUND: Acne vulgaris has increased in women over the past 10 years; it currently affects 20–30% of women. The physiopathology of adult female acne is distinguished from that of teenagers essentially by two factors: hormonal and inflammatory. On a therapeutic plan, the four types of systemic tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Poinas, Alexandra, Lemoigne, Marie, Le Naour, Sarah, Nguyen, Jean-Michel, Schirr-Bonnans, Solène, Riche, Valery-Pierre, Vrignaud, Florence, Machet, Laurent, Claudel, Jean-Paul, Leccia, Marie-Thérèse, Hainaut, Ewa, Beneton, Nathalie, Dert, Cécile, Boisrobert, Aurélie, Flet, Laurent, Chiffoleau, Anne, Corvec, Stéphane, Khammari, Amir, Dréno, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318446/
https://www.ncbi.nlm.nih.gov/pubmed/32586344
http://dx.doi.org/10.1186/s13063-020-04432-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318446/
https://www.ncbi.nlm.nih.gov/pubmed/32586344
http://dx.doi.org/10.1186/s13063-020-04432-w

Ejemplares similares